Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Anvirzel™ in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines
2013
International Union of Pharmacology nomenclature of adrenoceptors.
1994 StandoutNobel
Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinoma
1995
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
2003 Standout
Molecular biology of α-adrenergic receptors: implications for receptor classification and for structure-function relationships
1991 StandoutNobel
Presynaptic alterations associated with enhancement of evoked release and synthesis of norepinephrine in hippocampus of chronically cold-stressed rats
1993
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice
1991 StandoutNobel
Descending control of pain
2002 Standout
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Neuropeptide Y receptor 1 (NPY-Y1) expression in human heart failure and heart transplantation
1998 StandoutNobel
Gold nanoparticles in delivery applications☆
2008 Standout
The α-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys.
1997
Moxonidine
1992
Reversal of Multidrug Resistance by 7-O-Benzoylpyripyropene A in Multidrug-Resistant Tumor Cells.
2000 StandoutNobel
Renal-Cell Carcinoma
1996 Standout
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems
1990
Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns
1999 StandoutNobel
Medetomidine stereoisomers delineate two closely related subtypes of idazoxan (imidazoline) I-receptors in the guinea pig
1991
Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtype
1991
The role of imidazoline receptors in blood pressure regulation
1992
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
α2-Adrenergic Agonists for Regional Anesthesia
1996 Standout
Targeting multidrug resistance in cancer
2006 Standout
Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer☆
2004
Distribution of α2-adrenergic receptor mRNAs in the rat CNS
1991
Gene targeting — homing in on α2-adrenoceptor-subtype function
1997 StandoutNobel
p21 in cancer: intricate networks and multiple activities
2009 Standout
Imidazoline receptors: from discovery to antihypertensive therapy (facts and doubts)
1999
Gender Differences in Brain Metabolic and Plasma Catecholamine Responses to Alpha2-Adrenoceptor Blockade
1997
Extracellular brain cortical levels of noradrenaline in ischemia:
1991
α2C-Adrenoceptor-Overexpressing Mice Are Impaired in Executing Nonspatial and Spatial Escape Strategies
1998 StandoutNobel
Novel Glutathione-Dependent Thiopurine Prodrugs: Evidence for Enhanced Cytotoxicity in Tumor Cells and for Decreased Bone Marrow Toxicity in Mice
2002
Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice
1995 StandoutNobel
Autoradiography of adrenoceptors in rat and human brain: α-adrenoceptor and idazoxan binding sites
1991
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
L 1 ‐ IMIDAZOLINE RECEPTORS: HISTORICAL PERSPECTIVE
1992
Regulation of myocardial βARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing α1B-adrenergic receptors
2001 StandoutNobel
NNC-711, a novel potent and selective γ-aminobutyric acid uptake inhibitor: pharmacological characterization
1992
Imidazoline receptors, non-adrenergic idazoxan binding sites and α2-adrenoceptors in the human central nervous system
1994
Urolithiasis in pregnancy. II: management
2002
Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone
1994 StandoutNobel
Functional evidence for heterogeneity of peripheral prejunctional α2‐adrenoceptors
1990
Cisplatin: The first metal based anticancer drug
2019 Standout
Delineation of rat kidney α2A- and α2B-adrenoeeptors with [3H]RX821002 radiollgand binding: computer modelling reveals that guanfacine is an α2A-selective compound
1991
Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma.
1995
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Expression of α2 adrenoceptors during rat brain development—I. α2A messenger RNA expression
1996
VASCULOGENIC IMPOTENCE
2001
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
Cellular signalling of the receptor for advanced glycation end products (RAGE)
2013
Poly(lactide-co-glycolide acid)/biphasic calcium phosphate composite coating on a porous scaffold to deliver simvastatin for bone tissue engineering
2013
d-amphetamine and l-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the α2C-adrenergic receptor subtype
1998 StandoutNobel
Biological significance of agmatine, an endogenous ligand at imidazoline binding sites
2001
Differential localization of α2-adrenergic receptor subtypes in brain
1992
α2-Adrenoceptors and I2 sites in the mammalian central nervous system
1995
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Cloning and expression of the mouse homolog of the human α2-C2 adrenergic receptor
1992 StandoutNobel
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
2002 Standout
Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.
1997 StandoutNobel
Heterozygous α 2A -adrenergic receptor mice unveil unique therapeutic benefits of partial agonists
2002 StandoutNobel
Arterial hypertension and cancer
2013
Cardiovascular Regulation in Mice Lacking α 2 -Adrenergic Receptor Subtypes b and c
1996 StandoutScienceNobel
Mutation of the α2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine
2002 StandoutNobel
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation.
1992
Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications
2017 Standout
Antinociceptive Action of Nitrous Oxide Is Mediated by Stimulation of Noradrenergic Neurons in the Brainstem and Activation of α2BAdrenoceptors
2000 StandoutNobel
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Ischemic Cell Death in Brain Neurons
1999 Standout
European Hernia Society guidelines on the treatment of inguinal hernia in adult patients
2009 Standout
Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's drug discovery program for cancer and AIDS
1994 StandoutNobel
Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein
1992
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Statistical assessment of the learning curves of health technologies
2001
Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.
1992
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
1999 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Targeted Inhibition of the KLF6 Splice Variant, KLF6 SV1, Suppresses Prostate Cancer Cell Growth and Spread
2005
Gene targeting — homing in on α2-adrenoceptor-subtype function
1997 StandoutNobel
Works of R. Tschada being referenced
Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes
2003
RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner
2011
[3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
1989
Penile Revascularization in Nonresponders to Intracavernous Injections Using a Modified Microsurgical Technique
1992
P-170 Glycoprotein, Glutathione and Associated Enzymes in Relation to Chemoresistance of Primary Human Renal Cell Carcinomas
1990
Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT)
1990
[Pregnancy-induced changes in adrenergic receptors].
1991
Myocardial catecholamine metabolism in patients with chronic aortic regurgitation.
1982
[Retroperitoneoscopy. Technique and experiences with the first 100 patients].
1996
Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas.
1990